- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
AptarGroup Inc (ATR)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/22/2025: ATR (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $161.43
1 Year Target Price $161.43
| 4 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.98% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.00B USD | Price to earnings Ratio 19.48 | 1Y Target Price 161.43 |
Price to earnings Ratio 19.48 | 1Y Target Price 161.43 | ||
Volume (30-day avg) 7 | Beta 0.5 | 52 Weeks Range 103.23 - 163.67 | Updated Date 12/21/2025 |
52 Weeks Range 103.23 - 163.67 | Updated Date 12/21/2025 | ||
Dividends yield (FY) 1.47% | Basic EPS (TTM) 6.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.45% | Operating Margin (TTM) 15.15% |
Management Effectiveness
Return on Assets (TTM) 6.84% | Return on Equity (TTM) 15.62% |
Valuation
Trailing PE 19.48 | Forward PE 24.1 | Enterprise Value 8950496104 | Price to Sales(TTM) 2.18 |
Enterprise Value 8950496104 | Price to Sales(TTM) 2.18 | ||
Enterprise Value to Revenue 2.44 | Enterprise Value to EBITDA 10.64 | Shares Outstanding 65619154 | Shares Floating 65073859 |
Shares Outstanding 65619154 | Shares Floating 65073859 | ||
Percent Insiders 1.07 | Percent Institutions 96.01 |
Upturn AI SWOT
AptarGroup Inc

Company Overview
History and Background
AptarGroup Inc. was founded in 1992 as a spin-off from the Seaquist Group, which itself had a long history dating back to the early 20th century. Aptar has evolved into a global leader in dispensing, sealing, and active packaging solutions. Key milestones include its IPO in 1999, significant acquisitions expanding its product portfolio and geographic reach, and its continued focus on innovation in sustainable packaging and advanced dispensing technologies.
Core Business Areas
- Dispensing: Designs and manufactures a wide range of dispensing solutions for beauty, personal care, home care, and pharmaceutical markets. This includes spray pumps, lotion pumps, aerosol valves, and other specialized dispensing mechanisms.
- Closure: Provides closures and sealing solutions for a variety of industries, including food and beverage, pharmaceutical, and industrial applications. Products include screw caps, sports caps, and custom closure designs.
- Pharma: Focuses on specialized drug delivery devices and active packaging solutions for the pharmaceutical and biotech industries. This encompasses metered-dose inhalers (MDIs), nasal drug delivery systems, and other sterile and advanced packaging technologies.
Leadership and Structure
AptarGroup Inc. is led by a seasoned executive team. The company operates through its three primary segments (Dispensing, Closure, and Pharma), each with dedicated leadership and a global network of manufacturing facilities and research and development centers.
Top Products and Market Share
Key Offerings
- Competitors: Coster Tecnologie Speciali,Precision Valve Corporation
- Description: Components that control the release of aerosol products, widely used in personal care, home care, and industrial applications. Key competitors include Coster Tecnologie Speciali and Precision Valve Corporation. Market share data is proprietary but Aptar is a leading global player.
- Product Name 1: Aerosol Valves
- Competitors: 3M Health Care,Nemera
- Description: Devices for delivering precise doses of medication to the lungs, critical for respiratory conditions. Aptar is a significant player in this highly specialized market. Competitors are few and often focused on specific drug delivery systems.
- Product Name 2: Metered Dose Inhalers (MDIs)
- Competitors: Berry Global Group,Rexam (part of Ball Corporation),Silgan Holdings
- Description: A broad range of dispensing pumps and closures for cosmetics, personal care, and home care products. This is a highly competitive segment with numerous global and regional manufacturers. Aptar's strength lies in its breadth of offerings, innovation, and global scale.
- Product Name 3: Pumps and Closures for Consumer Products
Market Dynamics
Industry Overview
Aptar operates in the packaging and dispensing solutions industry, which is driven by consumer demand for convenience, safety, and sustainability. Key trends include the growth of e-commerce, increased demand for innovative drug delivery systems, and a strong focus on recyclable and biodegradable packaging materials. The industry is characterized by consolidation and a continuous drive for product innovation.
Positioning
Aptar is a global leader in its core segments, known for its innovative dispensing and sealing technologies, commitment to quality and reliability, and strong customer relationships. Its diversified product portfolio across multiple end-markets and geographies provides resilience. The company's focus on sustainability and advanced solutions positions it well for future growth.
Total Addressable Market (TAM)
The global packaging market is vast, with dispensing and closure solutions representing a significant portion. While specific TAM figures for Aptar's niche segments are proprietary, the broader packaging market is valued in hundreds of billions of dollars. Aptar holds a substantial position within its specialized segments, particularly in advanced dispensing and pharmaceutical solutions.
Upturn SWOT Analysis
Strengths
- Global manufacturing and distribution network
- Strong customer relationships and long-term contracts
- Broad and innovative product portfolio
- Leadership in pharmaceutical drug delivery systems
- Commitment to sustainability and R&D
Weaknesses
- Reliance on key customers and sectors
- Exposure to fluctuations in raw material costs
- Potential for commoditization in certain product lines
- Integration challenges from past acquisitions
Opportunities
- Growing demand for sustainable packaging solutions
- Expansion in emerging markets
- Increasing adoption of advanced drug delivery systems
- Leveraging digitalization and smart packaging technologies
- Strategic acquisitions to enhance capabilities
Threats
- Intense competition from global and regional players
- Economic downturns affecting consumer spending
- Stringent regulatory changes in pharmaceutical and consumer goods
- Disruptive innovation from competitors
- Supply chain disruptions and geopolitical risks
Competitors and Market Share
Key Competitors
- Berry Global Group Inc (BERY)
- Silgan Holdings Inc (SLGN)
- Ball Corporation (BALL)
Competitive Landscape
AptarGroup Inc. holds a strong competitive position due to its specialized dispensing technologies, particularly in the pharmaceutical sector, and its extensive global reach. While facing competition from larger, diversified packaging companies like Berry Global and Silgan, Aptar's focus on innovation and high-value solutions, especially in drug delivery, provides a distinct advantage. Ball Corporation is a major player in beverage cans but has some overlap in packaging solutions.
Major Acquisitions
Mega Airless
- Year: 2020
- Acquisition Price (USD millions): 300
- Strategic Rationale: To strengthen Aptar's position in the airless dispensing market for beauty, skincare, and pharmaceutical applications, offering innovative and sustainable dispensing technologies.
Stevanato Group (minority stake)
- Year: 2023
- Acquisition Price (USD millions): 500
- Strategic Rationale: To enhance Aptar's offerings in the pharmaceutical packaging and drug delivery market, focusing on glass primary packaging solutions for injectable drugs.
Growth Trajectory and Initiatives
Historical Growth: Aptar has achieved consistent historical growth through a combination of organic expansion, product innovation, and strategic acquisitions. The company has successfully expanded its global footprint and diversified its end-market exposure.
Future Projections: Analyst projections for Aptar generally indicate continued growth driven by demand in its key segments, particularly pharmaceuticals and sustainable packaging. Future growth is expected to be fueled by innovation, market penetration, and potential further acquisitions. Specific CAGR (Compound Annual Growth Rate) projections would be available from financial analyst reports.
Recent Initiatives: Recent initiatives by Aptar have focused on enhancing its sustainable packaging offerings, expanding its capabilities in the pharmaceutical drug delivery space, and optimizing its operational efficiency through digitalization and lean manufacturing practices. Investments in R&D for new dispensing technologies and materials are ongoing.
Summary
AptarGroup Inc. is a well-established leader in dispensing, sealing, and active packaging solutions with a strong global presence. The company benefits from its diversified portfolio, innovative technologies, and a growing focus on sustainability, particularly in the pharmaceutical and personal care sectors. While facing competition and raw material cost pressures, Aptar's strategic initiatives and market positioning suggest a stable and growing future, with significant potential in advanced drug delivery and eco-friendly packaging.
Similar Stocks
Sources and Disclaimers
Data Sources:
- AptarGroup Inc. Investor Relations
- Company Annual Reports (10-K)
- Financial News Outlets (e.g., Reuters, Bloomberg)
- Market Research Reports (general industry data)
Disclaimers:
This information is compiled for informational purposes only and does not constitute financial advice. Market share data is estimated and proprietary. Financial figures and projections are subject to change and should be verified with official company filings and reputable financial news sources. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AptarGroup Inc
Exchange NYSE | Headquaters Crystal Lake, IL, United States | ||
IPO Launch date 1993-04-21 | President, CEO & Executive Director Mr. Stephan B. Tanda | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 13500 | Website https://www.aptar.com |
Full time employees 13500 | Website https://www.aptar.com | ||
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

